ROTA, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 8.119
EU - Europa 4.014
AS - Asia 1.629
AF - Africa 56
Continente sconosciuto - Info sul continente non disponibili 22
SA - Sud America 17
OC - Oceania 8
Totale 13.865
Nazione #
US - Stati Uniti d'America 7.948
IT - Italia 942
CN - Cina 745
SE - Svezia 599
DE - Germania 574
IE - Irlanda 469
SG - Singapore 455
UA - Ucraina 413
RU - Federazione Russa 380
GB - Regno Unito 202
CA - Canada 164
HK - Hong Kong 149
VN - Vietnam 113
FI - Finlandia 109
FR - Francia 86
IN - India 62
AT - Austria 55
DK - Danimarca 52
ZA - Sudafrica 50
NL - Olanda 43
TR - Turchia 31
KR - Corea 24
BE - Belgio 21
EU - Europa 16
ES - Italia 13
JP - Giappone 13
IR - Iran 12
GR - Grecia 9
BR - Brasile 7
CH - Svizzera 7
MX - Messico 6
NO - Norvegia 6
AU - Australia 5
CZ - Repubblica Ceca 5
ID - Indonesia 5
RO - Romania 5
TH - Thailandia 5
A1 - Anonimo 4
CO - Colombia 4
PL - Polonia 4
PT - Portogallo 4
CL - Cile 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
MY - Malesia 2
OM - Oman 2
AR - Argentina 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
BZ - Belize 1
DZ - Algeria 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
ME - Montenegro 1
MU - Mauritius 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZM - Zambia 1
Totale 13.865
Città #
Woodbridge 978
Ann Arbor 953
Houston 709
Fairfield 661
Chandler 605
Jacksonville 449
Dublin 447
Ashburn 394
Dearborn 369
Singapore 368
Wilmington 312
Frankfurt am Main 298
New York 270
Seattle 265
Cambridge 257
Milan 257
Princeton 199
Santa Clara 168
Hong Kong 140
Nanjing 137
Shanghai 98
Altamura 95
Lawrence 82
Lachine 81
Beijing 62
Nanchang 57
Dong Ket 55
Vienna 52
Cape Town 50
San Diego 48
Shenyang 46
Guangzhou 43
Andover 39
Hebei 37
Ottawa 34
Tianjin 32
Jiaxing 28
Jinan 28
Helsinki 26
Lissone 22
Mountain View 22
Toronto 22
Changsha 21
Fremont 20
Hangzhou 19
Los Angeles 19
Zhengzhou 19
Boardman 17
Boston 17
Bologna 14
Brussels 14
Chicago 14
Huizen 14
London 14
Ningbo 14
Nürnberg 14
Kunming 13
Manchester 13
Norwalk 13
Falls Church 9
Dallas 8
Hefei 8
Lanzhou 8
Montréal 8
Pune 8
Rome 8
Edmonton 7
Fuzhou 7
Napoli 7
Padova 7
San Francisco 7
Stezzano 7
Taizhou 7
Torino 7
Verona 7
Washington 7
Bonndorf 6
Busto Arsizio 6
Munich 6
San Mateo 6
Bergamo 5
Foggia 5
Jakarta 5
Ozzano Monferrato 5
Perugia 5
Phoenix 5
Valencia 5
Valmadrera 5
Bari 4
Brescia 4
Cagliari 4
Chengdu 4
Groningen 4
Hanover 4
Hounslow 4
Indianapolis 4
Kyoto 4
Legnano 4
Nottingham 4
Pioltello 4
Totale 9.803
Nome #
Continuous monitoring of cerebral blood flow (CBF) and cerebral temperature in neurocritical care unit 281
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 236
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 223
High-Resolution Intracranial Pressure Burden and Outcome in Subarachnoid Hemorrhage 201
Intracerebral hemorrhage in intensive care unit: early prognostication fallacies. A single center retrospective study 197
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 195
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 195
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 192
An Effective and Safe Strategy to Target Normothermia in Neurocritical Patients 191
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 190
Health Related Quality of Life in the Major Liver Conditions 185
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 184
Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation 180
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 180
Alcohol drinking and multiple myeloma risk - A systematic review and meta-analysis of the dose-risk relationship 179
Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis 178
Light alcohol drinking and cancer: a meta-analysis 178
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 178
The impact of liver disease on the health-related quality of life 177
Health related quality of life in chronic liver diseases 176
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 173
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 173
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 172
A noninvasive index of atrial remodeling in patients with paroxysmal and persistent atrial fibrillation: a pilot study 170
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 170
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 170
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 169
Alcohol consumption and site-specific cancer risk: A comprehensive dose-response meta-analysis 169
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 168
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 167
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 166
Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysis 161
Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies 160
Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers - A systematic review and meta-analysis 159
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 159
Re: light drinking has positive public health consequences 159
Modelling body mass index and endometrial cancer risk in a pooled-analysis of three case-control studies 159
Alcohol consumption and lung cancer risk in never smokers: a meta-analysis 158
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk 158
External Ventricular and Lumbar Drain Device Infections in ICU Patients: A Prospective Multicenter Italian Study 157
Alcohol drinking and laryngeal cancer: Overall and dose-risk relation - A systematic review and meta-analysis 155
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 155
Random-effects meta-regression models for studying nonlinear dose-response relationship, with an application to alcohol and esophageal squamous cell carcinoma 154
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: Overall results and dose-risk relation 154
A meta-analysis on alcohol drinking and gastric cancer risk 153
Organ donation after brain death in refractory cardiac arrest treated with extracorporeal CPR 153
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 151
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 151
Single-Incision Versus Standard Multiple-Incision Laparoscopic Cholecystectomy: A Meta-analysis of Experimental and Observational Studies 150
Is multifocality a prognostic factor in childhood hepatoblastoma? 150
A prospective evaluation of short-term and long-term results from colonic stenting for palliation or as a bridge to elective operation versus immediate surgery for large-bowel obstruction 149
Alcohol drinking and cutaneous melanoma risk: A systematic review and dose-risk meta-analysis 148
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 148
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 148
Incidence of pain after craniotomy in children 146
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 145
Alcohol drinking and epithelial ovarian cancer risk. A systematic review and meta-analysis 145
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 2: Results by subsites 145
Alcohol consumption and prostate cancer risk: a meta-analysis of the dose-risk relation 143
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 142
Management of Chronic hepatitis C (CHC) Genotype 1 treatment-naive patients in an era of rising opportunities and costs - A cost-effectiveness analysis of treatment options 142
A meta-analysis on alcohol drinking and the risk of Hodgkin lymphoma 137
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 135
Finding the optimal cut-point for Gaussian and Gamma distributed biomarkers 134
A meta-analysis of alcohol consumption and the risk of brain tumours 132
Trajectories of early secondary insults after traumatic brain injury: a new approach to evaluate impact on outcome 131
Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1 130
Trajectories of early secondary insults correlate to outcomes of traumatic brain injury: results from a large, single centre, observational study 130
Incidence of inhibitors to recombinant factor VIII products – A meta-analysis of 1,852 previously untreated patients 129
Meta-analysis on incidence of inhibitors in patients with haemophilia A treated with recombinant factor VIII products 122
Organ donation in cardiac arrest patients treated with extracorporeal CPR: A single centre observational study 122
Optimal cut-point definition in biomarkers: The case of censored failure time outcome 119
A random-effects meta-regression model for studying nonlinear dose-response relationship 118
A simulation study comparing performance of minimum P-value and Youden index as methods to find optimal cut-points of continuous variables 118
Prospective multicentre cohort study evaluating the incidence of pain after craniotomy in children: first interim analysis. 117
Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis 116
Alcohol drinking and risk of leukemia-A systematic review and meta-analysis of the dose-risk relation 113
Donor safety in living donor liver donation: An Italian multicenter survey 113
Cut-Point Finding Methods For Continuous Biomarkers In The Presence Of Binary And Censored Failure Time Outcome 109
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies 109
Sofosbuvir and ribavirinin in HCV-infected patients listed for liver transplantation: A cost-effectiveness analysis 109
Cost-effectiveness of new direct-acting antivirals to prevent post-liver transplant recurrent hepatitis 109
Difference in health related quality of life of chronic liver diseases and general population 108
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 106
Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data 105
Intracranial pressure monitor insertion in traumatic brain injury: a single center, retrospective decision process analysis 104
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using “on demand” Approach: A Single Center Experience 102
Is there a difference in inhibitor incidence with recombinant products? A meta-analysis of 2000 previously untreated patients 100
Cut-pont finding methods for continuous biomarkers 98
Coffee consumption and risk of fractures: A systematic review and dose-response meta-analysis 93
Quantifying the Dose-Response Relationship Between Circulating Folate Concentrations and Colorectal Cancer in Cohort Studies: A Meta-Analysis Based on a Flexible Meta-Regression Model 92
Meta-Analysis on Incidence of Inhibitors in 1,945 Previously Untreated Patients Treated with Recombinant Factor VIII Products: Is There a Difference? 90
Factors influencing the decision to monitor intracranial pressure in traumatic brain injury. A large monocentric study 84
Cut-point identification in biomarkers for a censored failure time outcome 82
Cut-point identification in biomarkers for a censored failure time outcome 79
Does alcohol consumption increase the risk of cutaneous melanoma? Comments on a recent meta-analysis: reply from the authors 73
Dose-response relationship between cigarette smoking and site-specific cancer risk: Protocol for a systematic review with an original design combining umbrella and traditional reviews 73
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using" on demand" Approach: A Single Center Experience 72
Incidence of Thrombo-Embolic Events in Relation to Activated Prothrombin Complex Concentrate Exposure: A Literature Meta-Analysis 72
Totale 14.405
Categoria #
all - tutte 46.716
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.716


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.766 0 0 0 0 263 340 398 174 225 151 155 60
2020/20211.267 93 83 152 160 84 75 81 88 103 144 47 157
2021/2022954 40 79 109 98 33 90 29 78 50 84 71 193
2022/20232.189 232 687 171 198 134 338 18 144 178 7 64 18
2023/20241.591 52 69 52 89 174 520 273 75 94 18 16 159
2024/20251.177 227 363 185 127 275 0 0 0 0 0 0 0
Totale 14.405